The Impact of Timing of EGFR and IGF-1R Inhibition for Sensitizing Head and Neck Cancer to Radiation
Anticancer Research, 07/27/2012
Clinical Article
Matsumoto F et al. – These findings provide the rationale for clinical testing of the combination of ganitumab and panitumumab for the treatment of head and neck tumors (HNSCC)..



